These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 34969809)
1. Unusual oral presentation of acyclovir-resistant herpes simplex in an allogeneic haematopoietic stem cell transplant recipient. Saunsbury T; Harte M; Ion D BMJ Case Rep; 2021 Dec; 14(12):. PubMed ID: 34969809 [TBL] [Abstract][Full Text] [Related]
2. Delay of alternative antiviral therapy and poor outcomes of acyclovir-resistant herpes simplex virus infections in recipients of allogeneic stem cell transplant - a retrospective study. Ariza-Heredia EJ; Chemaly RF; Shahani LR; Jang Y; Champlin RE; Mulanovich VE Transpl Int; 2018 Jun; 31(6):639-648. PubMed ID: 29464765 [TBL] [Abstract][Full Text] [Related]
4. Successful clearance of cutaneous acyclovir-resistant, foscarnet-refractory herpes virus lesions with topical cidofovir in an allogeneic hematopoietic stem cell transplant patient. Muluneh B; Dean A; Armistead P; Khan T J Oncol Pharm Pract; 2013 Jun; 19(2):181-5. PubMed ID: 22635417 [TBL] [Abstract][Full Text] [Related]
5. Topical Treatment of Acyclovir-Resistant Herpes Simplex Virus Stomatitis after Allogeneic Hematopoietic Cell Transplantation. Heidenreich D; Kreil S; Mueller N; Jawhar M; Nolte F; Hofmann WK; Klein SA Oncol Res Treat; 2020; 43(12):672-678. PubMed ID: 33070144 [TBL] [Abstract][Full Text] [Related]
6. Improvement of refractory acyclovir-resistant herpes simplex virus type 1 infection by continuous acyclovir administration. Ikawa Y; Fujiki T; Nishimura R; Noguchi K; Koshino E; Fujiki A; Fukuda M; Kuroda R; Mase S; Araki R; Maeba H; Shiraki K; Yachie A J Infect Chemother; 2019 Jan; 25(1):65-67. PubMed ID: 30064949 [TBL] [Abstract][Full Text] [Related]
7. Acyclovir-resistant herpes simplex virus 1 infection early after allogeneic hematopoietic stem cell transplantation with T-cell depletion. Akahoshi Y; Kanda J; Ohno A; Komiya Y; Gomyo A; Hayakawa J; Harada N; Kameda K; Ugai T; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Terasako-Saito K; Kimura SI; Kikuchi M; Nakasone H; Kako S; Shiraki K; Kanda Y J Infect Chemother; 2017 Jul; 23(7):485-487. PubMed ID: 28262533 [TBL] [Abstract][Full Text] [Related]
8. Infection due to acyclovir resistant herpes simplex virus in patients undergoing allogeneic hematopoietic stem cell transplantation. Venard V; Dauendorffer JN; Carret AS; Corsaro D; Edert D; Bordigoni P; Le Faou A Pathol Biol (Paris); 2001 Sep; 49(7):553-8. PubMed ID: 11642018 [TBL] [Abstract][Full Text] [Related]
9. Extensive oral herpes simplex virus type 1 infection in a haematopoietic stem cell transplant recipient not responding to aciclovir. Moses SE; Osborne W; Valappil M; Collin M; Lee D; Waugh S; Jackson G; Parry CM; Crowley B J Clin Virol; 2011 Oct; 52(2):67-9. PubMed ID: 21665532 [No Abstract] [Full Text] [Related]
10. Treatment of an acyclovir and foscarnet-resistant herpes simplex virus infection with cidofovir in a child after an unrelated bone marrow transplant. Blot N; Schneider P; Young P; Janvresse C; Dehesdin D; Tron P; Vannier JP Bone Marrow Transplant; 2000 Oct; 26(8):903-5. PubMed ID: 11081393 [TBL] [Abstract][Full Text] [Related]
11. Successful foscarnet therapy for acyclovir-resistant mucocutaneous infection with herpes simplex virus in a recipient of allogeneic BMT. Verdonck LF; Cornelissen JJ; Smit J; Lepoutre J; de Gast GC; Dekker AW; Rozenberg-Arska M Bone Marrow Transplant; 1993 Feb; 11(2):177-9. PubMed ID: 8382096 [TBL] [Abstract][Full Text] [Related]
12. Association of the Emergence of Acyclovir-Resistant Herpes Simplex Virus Type 1 With Prognosis in Hematopoietic Stem Cell Transplantation Patients. Kakiuchi S; Tsuji M; Nishimura H; Yoshikawa T; Wang L; Takayama-Ito M; Kinoshita H; Lim CK; Fujii H; Yamada S; Harada S; Oka A; Mizuguchi M; Taniguchi S; Saijo M J Infect Dis; 2017 Mar; 215(6):865-873. PubMed ID: 28453848 [TBL] [Abstract][Full Text] [Related]